Add 2 More Reports For 20% off

Report Overview

2023

Base Year

2017-2023

Historical Year

2024-2032

Forecast Year

Global Contraceptive Pills Market Outlook

The global contraceptive pills market size reached a value of USD 19.39 billion in 2023. The market is further expected to grow at a CAGR of 3.9% during the forecast period of 2024-2032, likely to attain a value of USD 27.41 billion by 2032. The growth of the market is likely to be driven by the rapid technological developments.

contraceptive pills market

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

North America to be Among the Significant Regional Markets for Contraceptive Pills

North America is anticipated to account for a significant share of the global contraceptive pills market in the forecast period. The region is projected to uphold its dominance throughout the forecast period, owing to the high incidence of unintended pregnancies, rise in awareness regarding contraceptive pills, the surge in adoption of modern contraceptive drugs, and an alarming increase in the prevalence of sexually transmitted diseases, such as HIV/AIDS. The United States controls a significant portion of the North American contraceptive pill market. The United States government has initiated several awareness programs about contraception and family planning, which has fuelled the industry's revenue. Several organisations are also working in the country to accomplish strategic projects. According to data published by the Bill & Melinda Gates Foundation in 2023, the foundation plans to spend USD 280 million per year from 2021 to 2030 on developing new and improved contraceptive technologies, supporting family planning programmes that reflect local community preferences, and allowing women and girls to be in control of their contraceptive care.

Due to a large population base and proactive activities by governmental organisations for birth control and awareness within developing countries, Asia Pacific is expected to increase at the fastest rate during the projected period. In addition, the availability of cost-effective contraceptive pills in this region proposes profitable opportunities for contraceptive drug manufacturers. The launch of awareness programs by government agencies and other regulatory bodies to increase the homecare usage of contraceptive pills is likely to drive the contraceptive pills market in the Asia Pacific region.

Market Segmentations

contraceptive pills market by segments

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

The contraceptive pill, also known as the birth control pill, is a kind of birth control administered orally to women. It contains an oestrogen and a progestogen combination (specifically a progestin). When used correctly, it disrupts the menstrual cycle, preventing ovulation and pregnancy.

By type, the market includes:

  • Progestin-only Pills
  • Combines Contraceptives Pills

The several distribution channels of the market are:

  • Online Pharmacy
  • Hospital Pharmacy
  • Retail Pharmacy
  • Public Channel and NGO
  • Clinics
  • Others

The regional markets for the contraceptive pills industry can be divided into North America, Europe, the Asia Pacific, Latin America, the Middle East and Africa.

contraceptive pills market by region

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

Rising Awareness Among People Augmenting the Market Growth

The rising awareness among consumers about sexual health is expected to increase the demand and adoption of birth control methods, thereby augmenting the growth of contraceptive pills market. The upsurge in contraception has reduced the risk of sexually transmitted infections and enhanced health-related outcomes, comprising maternal and infant mortality. The rise in awareness of modern contraceptives, increasing use of safe and effective oral pills, and health complications related to teenage pregnancies further stimulate market expansion. Also, various government programs have increased access to contraceptives, which help prevent unwanted pregnancies in teenagers. Development, approval, and commercialisation of new, more effective, and long-acting reversible contraceptive methods are expected to drive the industry growth during the forecast period. For instance, Agile Therapeutics developed a hormonal patch, Twirla, introduced in the United States in the fourth quarter of 2020. The launch of generic and low-cost drugs and devices has led to an increase in the demand for contraceptives by teenagers. Further, the rising number of unwanted pregnancies is also one of the major factors driving the demand for contraceptive pills, thereby contributing to the market growth.

Key Players in the Global Market for Contraceptive Pills

The report gives a detailed analysis of the following key players in the global contraceptive pills market, covering their competitive landscape, capacity, and latest developments like mergers, acquisitions, and investments, expansions of capacity, and plant turnarounds:

  • Janssen Global Services, LLC
  • Pfizer Inc.
  • Teva Pharmaceuticals Industry Ltd.
  • Merck & Co. Inc.
  • Allergan, plc
  • Others

The comprehensive EMR report provides an in-depth assessment of the market based on the Porter's five forces model along with giving a SWOT analysis.

Key Highlights of the Report

REPORT FEATURES DETAILS
Base Year 2023
Historical Period 2017-2023
Forecast Period 2024-2032
Scope of the Report

Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:

  • Type
  • Drug Type
  • Therapy Type
  • Age Group
  • Distribution Channel
  • Region
Breakup by Type
  • Progestin Pills
  • Combination Pills
    • Monophasic
    • Triphasic
    • Others
Breakup by Drug Type
  • Generics
  • Branded
Breakup by Therapy Type
  • Monotherapy
  • Combined Contraceptives
Breakup by Age Group
  • 15-45 Years
  • Above 45 Years
Breakup by Distribution Channel
  • Hospital Pharmacy
  • Retail Pharmacy
  • Online Channel
  • Public Channel
  • Others
Breakup by Region
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa
Market Dynamics
  • Market Drivers and Constraints
  • SWOT Analysis
  • Porter’s Five Forces Model 
  • Key Demand Indicators
  • Key Price Indicators
  • Industry Events, Initiatives, and Trends 
  • Value Chain Analysis
Supplier Landscape
  • Market Structure
  • Company Profiles
    • Financial Analysis
    • Product Portfolio
    • Demographic Reach and Achievements
    • Mergers and Acquisitions
    • Certifications
Companies Covered
  • Piramal Enterprises Ltd.
  • Agile Therapeutics
  • Johnson & Johnson Services, Inc.
  • Abbive Inc.
  • Merck & Co Inc.
  • Teva Pharmaceuticals Industries Ltd.
  • Bayer AG
  • Pfizer Inc.
  • Helm AG.
  • Reckitt Benckiser Group PLC
  • Viatris Inc.
  • Amneal Pharmaceuticals LLC
  • Bayer AG
  • Allergan plc.
  • Agile Therapeutics

*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*

Looking for specific insights?

Get in touch with us for a customized solution tailored to your unique requirements and save upto 35%!

Key Questions Answered in the Report

In 2023, the global contraceptive pills market attained a value of nearly USD 19.39 billion.

The market is projected to grow at a CAGR of 3.9% between 2024 and 2032.

The major drivers of the market include the rise in the prevalence of sexually transmitted diseases, large population base, rise in awareness of modern contraceptives, increasing use of safe and effective oral pills, various government programs, commercialisation of new, more effective, and long-acting reversible contraceptive.

The rising awareness about sexual health and the increasing number of unwanted pregnancies are the key industry trends propelling the market's growth.

The major regions in the industry are North America, Latin America, the Middle East and Africa, Europe, and the Asia Pacific.

The different types of contraceptive pills include progestin-only pills and combined contraceptive pills.

The several distribution channels of the market include online pharmacy, hospital pharmacy, retail pharmacy, public channel and NGO, and clinics, among others.

The major players in the industry are Janssen Global Services, LLC, Pfizer Inc., Teva Pharmaceuticals Industry Ltd., Merck & Co. Inc., and Allergan, plc, among others.

Purchase Full Report

Datasheet

 

USD 2,969

USD 2,699

tax inclusive*

  • Selected Sections, One User
  • Printing Not Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Single User License

One User

USD 5,499

USD 4,999

tax inclusive*

  • All Sections, One User
  • One Print Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Five User License

Five Users

USD 6,599

USD 5,999

tax inclusive*

  • All Sections, Five Users
  • Five Prints Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Corporate License

Unlimited Users

USD 7,699

USD 6,999

tax inclusive*

  • All Sections, Unlimited Users
  • Unlimited Prints Allowed
  • Email Delivery in PDF + Excel
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

How To Order

Our step-by-step guide will help you select, purchase, and access your reports swiftly, ensuring you get the information that drives your decisions, right when you need it.

Select License Type

Choose the right license for your needs and access rights.

Click on ‘Buy Now’

Add the report to your cart with one click and proceed to register.

Select Mode of Payment

Choose a payment option for a secure checkout. You will be redirected accordingly.

Strategic Solutions for Informed Decision-Making

Connect For More Information

Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.

Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.

We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.

Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.

We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.

We’re here to help answer any questions about our products and services.

Contact us

Our Offices


Australia

63 Fiona Drive, Tamworth, NSW

+61 448 06 17 27

India

C130 Sector 2 Noida, Uttar Pradesh 201301

+91-858-608-1494

Philippines

40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City,1226.

+63 287899028, +63 967 048 3306

United Kingdom

6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London

+44-753-713-2163

United States (Head Office)

30 North Gould Street, Sheridan, WY 82801

+1-415-325-5166

Vietnam

193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City

+84865399124

30 North Gould Street, Sheridan, WY 82801

+1-415-325-5166

63 Fiona Drive, Tamworth, NSW

+61 448 06 17 27

C130 Sector 2 Noida, Uttar Pradesh 201301

+91-858-608-1494

40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City, 1226.

+63 287899028, +63 967 048 3306

6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London

+44-753-713-2163

193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City

+84865399124